- DocumentThe BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2uploaded byivanlch
- DocumentTrombosis en MM 2020uploaded byivanlch
- DocumentGuias ASH cancer y trombosis 2021 (1)uploaded byivanlch
- DocumentCómo evalúo y manejo el riesgo de hemorragia en pacientes tratados por tromboembolismo venosouploaded byivanlch
- DocumentTrasplante de células progenitoras hematopoyéticasuploaded byivanlch
- DocumentTargeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemiauploaded byivanlch
- DocumentBortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA) a randomised, open-label, phase 3 studyuploaded byivanlch
- Documentbenefits.pdfuploaded byivanlch
- DocumentBortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.pdfuploaded byivanlch
- DocumentApproach to the patient with neutropenia in childhood.pdfuploaded byivanlch
- DocumentAcute basophilic leukemia associated with the FUS-ERG fusion gene.pdfuploaded byivanlch
- DocumentAnemia sideroblástica..pdfuploaded byivanlch
- DocumentBortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.pdfuploaded byivanlch
- Documentbenefits.pdfuploaded byivanlch
- DocumentAnemia sideroblástica..pdfuploaded byivanlch
- DocumentApproach to the patient with neutropenia in childhood.pdfuploaded byivanlch
- DocumentAcute basophilic leukemia associated with the FUS-ERG fusion gene.pdfuploaded byivanlch
- DocumentTransfusion Practices ed6 Harmening.pdfuploaded byivanlch
- DocumentModern Blood Banking & Transfusion Practices ed6 Harmening-235-257.pdfuploaded byivanlch
- DocumentModern Blood Banking & Transfusion Practices Ed6 Harmening-235-257uploaded byivanlch